- Could You Spot the Silent Symptoms of Stress?
- Gas Stoves Could Leave Your Lungs Vulnerable to Nitrogen Dioxide
- Key Therapy Equally Effective for Women, Men With Narrowed Leg Arteries
- Doctors Describe Texas Dairy Farm Worker’s Case of Bird Flu
- Does Preschool Boost Kids’ Long-Term Academic Success? Study Finds Mixed Results
- AI Might Spot Rare Diseases in Patients Years Earlier
- An Orangutan Healed Himself With Medicinal Plant
- Quit-Smoking Meds Not Working for You? Try Upping the Dose
- Fewer Americans Are Suffering Most Dangerous Form of Heart Attack
- Even Skipping Meat for One Meal Helps Liver Disease Patients
New Blood Pump System Approved
The Impella 2.5 System has been approved by the U.S. Food and Drug Administration to maintain stable heart function and blood circulation during high-risk cardiac operations, the agency said in a news release.
The miniature blood pump is sanctioned for coronary artery disease patients during higher-risk procedures such as angioplasty, when a blocked artery is unclogged using an inflated balloon, the agency said.
The system is guided into the left ventricle of the heart via a catheter that’s typically inserted into a leg vein. An external controller and monitor turns the pump on and off, measures heart function and allows doctors to adjust the pump as needed, the FDA said.
People with coronary artery disease commonly have diminished blood flow to the heart, which could lead to serious complications during surgery, the agency said.
The Impella System is produced by Abiomed Inc., based in Danvers, Mass.
More information
The FDA has more about this approval.
Source: HealthDay
Copyright © 2024 HealthDay. All rights reserved.